Public Profile

SIRIO PHARMA CO

SIRIO PHARMA CO., a leading player in the pharmaceutical industry, is headquartered in China (CN) and operates extensively across Asia and beyond. Founded in 2002, the company has established itself as a key provider of high-quality pharmaceutical products and services, specialising in contract manufacturing and development. SIRIO PHARMA is renowned for its innovative approach to drug formulation and delivery, offering a diverse range of core products, including solid dosage forms and advanced delivery systems. The company’s commitment to quality and compliance has earned it a strong market position, with notable achievements in regulatory approvals and partnerships with global pharmaceutical firms. With a focus on excellence and customer satisfaction, SIRIO PHARMA continues to drive advancements in the pharmaceutical sector.

DitchCarbon Score

How does SIRIO PHARMA CO's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

21

Industry Average

Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

25

Industry Benchmark

SIRIO PHARMA CO's score of 21 is lower than 92% of the industry. This can give you a sense of how well the company is doing compared to its peers.

8%

Let us know if this data was useful to you

SIRIO PHARMA CO's reported carbon emissions

SIRIO PHARMA CO, headquartered in China (CN), currently does not have available carbon emissions data for recent years. As a result, specific figures regarding their emissions in kg CO2e, including Scope 1, 2, or 3 emissions, are not provided. In the absence of concrete emissions data, it is important to note that SIRIO PHARMA CO has not outlined any specific reduction targets or climate pledges. This lack of publicly available commitments may reflect a broader industry context where many companies are increasingly focusing on sustainability and carbon neutrality. For stakeholders and environmentally conscious consumers, the absence of detailed emissions reporting and climate commitments may raise questions about the company's approach to climate change and environmental responsibility.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. SIRIO PHARMA CO's primary industry is Research and development services (73), which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for SIRIO PHARMA CO is in CN, which we do not have grid emissions data for.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

SIRIO PHARMA CO is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero

Similar Organizations

Catalent

US
Research and development services (73)
Updated 5 days ago

Aenova Holding GmbH

DE
Chemicals nec
Updated about 2 months ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers